{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:12:02Z","timestamp":1789657922830,"version":"4.0.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T00:00:00Z","timestamp":1642550400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.virs.2022.01.017","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T18:36:17Z","timestamp":1642617377000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Updates on CRISPR-based gene editing in HIV-1\/AIDS therapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Zhihao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-455X","authenticated-orcid":false,"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7941-2344","authenticated-orcid":false,"given":"Shuliang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2022.01.017_bib1","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","article-title":"Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza","volume":"181","author":"Abbott","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib2","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib4","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/00002030-199606000-00002","article-title":"Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry","volume":"10","author":"Bagasra","year":"1996","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2022.01.017_bib5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1126\/science.1138140","article-title":"CRISPR provides acquired resistance against viruses in prokaryotes","volume":"315","author":"Barrangou","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1089\/aid.1.1983.1.275","article-title":"Guidelines for confidentiality in research on AIDS","volume":"1","author":"Bayer","year":"1983","journal-title":"AIDS Res."},{"key":"10.1016\/j.virs.2022.01.017_bib7","doi-asserted-by":"crossref","first-page":"23104","DOI":"10.1074\/jbc.M703485200","article-title":"Functional links between the fusion peptide-proximal polar segment and membrane-proximal region of human immunodeficiency virus gp41 in distinct phases of membrane fusion","volume":"282","author":"Bellamy-McIntyre","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.virs.2022.01.017_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/382829a0","article-title":"The lymphocyte chemoattractant SDF-1 is a ligand for LESTR\/fusin and blocks HIV-1 entry","volume":"382","author":"Bleul","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib9","doi-asserted-by":"crossref","first-page":"E7249","DOI":"10.1073\/pnas.1516305112","article-title":"Specific induction of endogenous viral restriction factors using CRISPR\/Cas-derived transcriptional activators","volume":"112","author":"Bogerd","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.01.017_bib10","article-title":"Update on acquired immune deficiency syndrome (AIDS)--United States","volume":"31","year":"1982","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nature24268","article-title":"Enhanced proofreading governs CRISPR-Cas9 targeting accuracy","volume":"550","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/v10010040","article-title":"CRISPR-cas targeting of host genes as an antiviral strategy","volume":"10","author":"Chen","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.01.017_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41564-018-0179-6","article-title":"HIV-2\/SIV viral protein X counteracts HUSH repressor complex","volume":"3","author":"Chougui","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virs.2022.01.017_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1086\/527324","article-title":"Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy","volume":"197","author":"Chun","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2022.01.017_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib17","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/487439a","article-title":"HIV: shock and kill","volume":"487","author":"Deeks","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/v13010024","article-title":"Editing of the TRIM5 gene decreases the permissiveness of human T lymphocytic cells to HIV-1","volume":"13","author":"D\u00e9saulniers","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.01.017_bib19","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41587-020-0414-6","article-title":"Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors","volume":"38","author":"Doman","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191709","article-title":"Editing of the human TRIM5 gene to introduce mutations with the potential to inhibit HIV-1","volume":"13","author":"Dufour","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2022.01.017_bib21","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.it.2012.07.001","article-title":"Developing strategies for HIV-1 eradication","volume":"33","author":"Durand","year":"2012","journal-title":"Trends Immunol."},{"key":"10.1016\/j.virs.2022.01.017_bib22","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molcel.2017.04.008","article-title":"RNA targeting by functionally orthogonal type VI-A CRISPR-cas enzymes","volume":"66","author":"East-Seletsky","year":"2017","journal-title":"Mol. Cell."},{"key":"10.1016\/j.virs.2022.01.017_bib23","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.01.017_bib25","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1073\/pnas.87.12.4650","article-title":"Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41","volume":"87","author":"Freed","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.01.017_bib26","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.molcel.2019.09.013","article-title":"Programmable inhibition and detection of RNA viruses using Cas13","volume":"76","author":"Freije","year":"2019","journal-title":"Mol. Cell."},{"key":"10.1016\/j.virs.2022.01.017_bib27","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1093\/nar\/gkaa226","article-title":"Extinction of all infectious HIV in cell culture by the CRISPR-Cas12a system with only a single crRNA","volume":"48","author":"Gao","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virs.2022.01.017_bib28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib29","first-page":"1548905","article-title":"SERINC as a restriction factor to inhibit viral infectivity and the interaction with HIV","volume":"2017","author":"Gonzalez-Enriquez","year":"2017","journal-title":"J.\u00a0Immunol. Res."},{"key":"10.1016\/j.virs.2022.01.017_bib30","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41587-020-0535-y","article-title":"A\u00a0dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing","volume":"38","author":"Gr\u00fcnewald","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib32","doi-asserted-by":"crossref","first-page":"146446","DOI":"10.1016\/j.brainres.2019.146446","article-title":"Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: role of dysregulated autophagy","volume":"1724","author":"Guo","year":"2019","journal-title":"Brain Res."},{"key":"10.1016\/j.virs.2022.01.017_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5\u039432\/\u039432 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib34","doi-asserted-by":"crossref","first-page":"15577","DOI":"10.1038\/srep15577","article-title":"Genome editing of CXCR4 by CRISPR\/cas9 confers cells resistant to HIV-1 infection","volume":"5","author":"Hou","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib35","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1038\/s41467-021-21337-7","article-title":"PrimeDesign software for rapid and simplified design of prime editing guide RNAs","volume":"12","author":"Hsu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.01.017_bib36","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.01.017_bib37","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.celrep.2016.09.080","article-title":"A\u00a0Cas9 ribonucleoprotein platform for functional genetic studies of HIV-host interactions in primary human T cells","volume":"17","author":"Hultquist","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib38","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/507312","article-title":"Prevalence of CXCR4 tropism among antiretroviral-treated HIV-1-infected patients with detectable viremia","volume":"194","author":"Hunt","year":"2006","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.virs.2022.01.017_bib39","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1056\/NEJMc1412279","article-title":"More on shift of HIV tropism in stem-cell transplantation with CCR5 delta32\/delta32 mutation","volume":"371","author":"H\u00fctter","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.01.017_bib40","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.3390\/v7082816","article-title":"CCR5 targeted cell therapy for HIV and prevention of viral escape","volume":"7","author":"H\u00fctter","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.01.017_bib41","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/mt.2016.7","article-title":"Specific reactivation of latent HIV-1 by dCas9-SunTag-VP64-mediated guide RNA targeting the HIV-1 promoter","volume":"24","author":"Ji","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.01.017_bib42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A\u00a0programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib43","article-title":"A\u00a0cryptic site of vulnerability on the receptor binding domain of the SARS-CoV-2 spike glycoprotein","author":"Joyce","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.virs.2022.01.017_bib44","doi-asserted-by":"crossref","first-page":"e268","DOI":"10.1038\/mtna.2015.42","article-title":"CCR5 disruption in induced pluripotent stem cells using CRISPR\/Cas9 provides selective resistance of immune cells to CCR5-tropic HIV-1 virus","volume":"4","author":"Kang","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.virs.2022.01.017_bib45","doi-asserted-by":"crossref","first-page":"7552","DOI":"10.1073\/pnas.0802203105","article-title":"Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection","volume":"105","author":"Keele","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.01.017_bib46","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/s41596-019-0210-2","article-title":"SHERLOCK: nucleic acid detection with CRISPR nucleases","volume":"14","author":"Kellner","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virs.2022.01.017_bib47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41587-020-0677-y","article-title":"Predicting the efficiency of prime editing guide RNAs in human cells","volume":"39","author":"Kim","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib48","article-title":"Mutant Cas9-transcriptional activator activates HIV-1 in U1 cells in the presence and absence of LTR-specific guide RNAs","volume":"2017","author":"Kim","year":"2017","journal-title":"Matters (Zur)"},{"key":"10.1016\/j.virs.2022.01.017_bib49","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cell.2018.02.033","article-title":"Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors","volume":"173","author":"Konermann","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib52","doi-asserted-by":"crossref","first-page":"194656","DOI":"10.1016\/j.bbagrm.2020.194656","article-title":"CRISPRi-mediated depletion of Spt4 and Spt5 reveals a role for DSIF in the control of HIV latency","volume":"1864","author":"Krasnopolsky","year":"2021","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.virs.2022.01.017_bib53","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.devcel.2020.07.013","article-title":"CRISPR-Cas13d induces efficient mRNA knockdown in animal embryos","volume":"54","author":"Kushawah","year":"2020","journal-title":"Dev. Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib54","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.cell.2018.08.062","article-title":"NONO detects the nuclear HIV capsid to promote cGAS-mediated innate immune activation","volume":"175","author":"Lahaye","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib55","doi-asserted-by":"crossref","first-page":"41331","DOI":"10.1074\/jbc.M111.299826","article-title":"Role for the terminal clasp of HIV-1 gp41 glycoprotein in the initiation of membrane fusion","volume":"286","author":"Lay","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.virs.2022.01.017_bib56","doi-asserted-by":"crossref","first-page":"41968","DOI":"10.1038\/srep41968","article-title":"A\u00a0combinational CRISPR\/Cas9 gene-editing approach can halt HIV replication and prevent viral escape","volume":"7","author":"Lebbink","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib57","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1099\/vir.0.000139","article-title":"Inhibition of HIV-1 infection of primary CD4+ T-cells by gene editing of CCR5 using adenovirus-delivered CRISPR\/Cas9","volume":"96","author":"Li","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.virs.2022.01.017_bib58","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.omtn.2020.01.028","article-title":"CRISPR-Cas13a cleavage of dengue virus NS3 gene efficiently inhibits viral replication","volume":"19","author":"Li","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.virs.2022.01.017_bib59","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.tibtech.2018.12.005","article-title":"CRISPR\/Cas systems towards next-generation biosensing","volume":"37","author":"Li","year":"2019","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009055","article-title":"Identification of unrecognized host factors promoting HIV-1 latency","volume":"16","author":"Li","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2022.01.017_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007498","article-title":"Reiterative Enrichment and Authentication of CRISPRi Targets (REACT) identifies the proteasome as a key contributor to HIV-1 latency","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virs.2022.01.017_bib62","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","volume":"6","author":"Liao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.01.017_bib63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/mt.2015.213","article-title":"CRISPR-mediated activation of latent HIV-1 expression","volume":"24","author":"Limsirichai","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.01.017_bib64","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41587-020-0455-x","article-title":"Prime genome editing in rice and wheat","volume":"38","author":"Lin","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib65","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1093\/nar\/gku402","article-title":"CRISPR\/Cas9 systems have off-target activity with insertions or deletions between target DNA and guide RNA sequences","volume":"42","author":"Lin","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virs.2022.01.017_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2016.12.031","article-title":"Two distant catalytic sites are responsible for C2c2 RNase activities","volume":"168","author":"Liu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib67","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1038\/s41598-018-26894-4","article-title":"HIV-1 inhibition in cells with CXCR4 mutant genome created by CRISPR-Cas9 and piggyBac recombinant technologies","volume":"8","author":"Liu","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib68","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12033-014-9768-7","article-title":"A\u00a0novel approach to block HIV-1 coreceptor CXCR4 in non-toxic manner","volume":"56","author":"Liu","year":"2014","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13578-017-0174-2","article-title":"Genome editing of the HIV co-receptors CCR5 and CXCR4 by CRISPR-Cas9 protects CD4(+) T cells from HIV-1 infection","volume":"7","author":"Liu","year":"2017","journal-title":"Cell Biosci."},{"key":"10.1016\/j.virs.2022.01.017_bib70","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13578-020-00444-w","article-title":"Genome editing of CCR5 by AsCpf1 renders CD4(+)T cells resistance to HIV-1 infection","volume":"10","author":"Liu","year":"2020","journal-title":"Cell Biosci."},{"key":"10.1016\/j.virs.2022.01.017_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01757-18","article-title":"HIV-1 antisense protein of different clades induces autophagy and associates with the autophagy factor p62","volume":"93","author":"Liu","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.01.017_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02128-18","article-title":"The polar region of the HIV-1 envelope protein determines viral fusion and infectivity by stabilizing the gp120-gp41 association","volume":"93","author":"Lu","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.01.017_bib73","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer","volume":"26","author":"Lu","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.01.017_bib74","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s13059-019-1881-2","article-title":"CRISPR-Cas13d mediates robust RNA virus interference in plants","volume":"20","author":"Mahas","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.virs.2022.01.017_bib75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-1-4939-2687-9_4","article-title":"Annotation and classification of CRISPR-cas systems","volume":"1311","author":"Makarova","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virs.2022.01.017_bib76","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib77","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41467-020-19821-7","article-title":"CRISPR based editing of SIV proviral DNA in ART treated non-human primates","volume":"11","author":"Mancuso","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2022.01.017_bib78","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","article-title":"Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9","volume":"15","author":"Mandal","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3390\/v11020100","article-title":"HIV-1 fusion with CD4+ T cells is promoted by proteins involved in endocytosis and intracellular membrane trafficking","volume":"11","author":"Marin","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.01.017_bib80","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41587-020-0412-8","article-title":"Continuous evolution of SpCas9 variants compatible with non-G PAMs","volume":"38","author":"Miller","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1182\/blood-2013-01-306647","article-title":"Immune responses to AAV vectors: overcoming barriers to successful gene therapy","volume":"122","author":"Mingozzi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.virs.2022.01.017_bib82","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/JVI.03333-13","article-title":"Epigenetic regulation of HIV-1 latency in astrocytes","volume":"88","author":"Narasipura","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.virs.2022.01.017_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.meegid.2017.06.027","article-title":"Investigating CRISPR-Cas systems in Clostridium botulinum via bioinformatics tools","volume":"54","author":"Negahdaripour","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.virs.2022.01.017_bib84","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.3390\/v12101154","article-title":"Targeted chromatinization and repression of HIV-1 provirus transcription with repurposed CRISPR\/Cas9","volume":"12","author":"Olson","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.01.017_bib85","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3390\/v12111223","article-title":"Multiplexed tat-targeting CRISPR-cas9 protects T cells from acute HIV-1 infection with inhibition of viral escape","volume":"12","author":"Ophinni","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.virs.2022.01.017_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.omtm.2017.04.002","article-title":"Integrase-deficient lentiviral vector as an all-in-one platform for highly efficient CRISPR\/Cas9-Mediated gene editing","volume":"5","author":"Ortinski","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.virs.2022.01.017_bib87","first-page":"65","article-title":"HIV tropism shift: new paradigm on cell therapy strategies for HIV cure","volume":"17","author":"Poveda","year":"2015","journal-title":"AIDS Rev."},{"key":"10.1016\/j.virs.2022.01.017_bib88","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.omtn.2018.05.012","article-title":"Inducing CCR5\u039432\/\u039432 homozygotes in the human Jurkat CD4+ cell line and primary CD4+ cells by CRISPR-cas9 genome-editing technology","volume":"12","author":"Qi","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.virs.2022.01.017_bib89","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature15399","article-title":"HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation","volume":"526","author":"Rosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.virs.2022.01.017_bib90","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/mt.2015.202","article-title":"Potent and targeted activation of latent HIV-1 using the CRISPR\/dCas9 activator complex","volume":"24","author":"Saayman","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.01.017_bib91","doi-asserted-by":"crossref","first-page":"198282","DOI":"10.1016\/j.virusres.2020.198282","article-title":"CRISPR systems: novel approaches for detection and combating COVID-19","volume":"294","author":"Safari","year":"2021","journal-title":"Virus Res."},{"key":"10.1016\/j.virs.2022.01.017_bib92","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10571-019-00761-w","article-title":"CRISPR system: a high-throughput toolbox for research and treatment of Parkinson's disease","volume":"40","author":"Safari","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.virs.2022.01.017_bib93","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/s41587-020-0509-0","article-title":"Base editors for simultaneous introduction of C-to-T and A-to-G mutations","volume":"38","author":"Sakata","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib94","doi-asserted-by":"crossref","first-page":"16104","DOI":"10.1038\/s41598-019-52616-5","article-title":"Improved Cas9 activity by specific modifications of the tracrRNA","volume":"9","author":"Scott","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib95","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1089\/aid.2020.0055","article-title":"Analysis of CRISPR\/Cas9 guide RNA efficiency and specificity against genetically diverse HIV-1 isolates","volume":"36","author":"Sessions","year":"2020","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.virs.2022.01.017_bib96","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.molcel.2015.10.008","article-title":"Discovery and functional characterization of diverse class 2 CRISPR-cas systems","volume":"60","author":"Shmakov","year":"2015","journal-title":"Mol. Cell."},{"key":"10.1016\/j.virs.2022.01.017_bib97","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nm880","article-title":"Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells","volume":"9","author":"Siliciano","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2022.01.017_bib98","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib99","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1189\/jlb.0503219","article-title":"Macrophage HIV-1 infection and the gastrointestinal tract reservoir","volume":"74","author":"Smith","year":"2003","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.virs.2022.01.017_bib100","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.01.017_bib101","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAD.0000000000001796","article-title":"Global HIV neurology: a comprehensive review","volume":"33","author":"Thakur","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.virs.2022.01.017_bib102","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12977-017-0375-0","article-title":"Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection","volume":"14","author":"Wang","year":"2017","journal-title":"Retrovirology"},{"key":"10.1016\/j.virs.2022.01.017_bib103","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2018.04.002","article-title":"Genome scale screening identification of SaCas9\/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection","volume":"250","author":"Wang","year":"2018","journal-title":"Virus Res."},{"key":"10.1016\/j.virs.2022.01.017_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115987","article-title":"CCR5 gene disruption via lentiviral vectors expressing Cas9 and single guided RNA renders cells resistant to HIV-1 infection","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virs.2022.01.017_bib105","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.celrep.2016.03.042","article-title":"CRISPR\/Cas9-Derived mutations both inhibit HIV-1 replication and accelerate viral escape","volume":"15","author":"Wang","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib106","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12977-019-0477-y","article-title":"CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4(+) T cells and hematopoietic stem\/progenitor cells promotes HIV-1 resistance and CD4(+) T cell enrichment in humanized mice","volume":"16","author":"Xiao","year":"2019","journal-title":"Retrovirology"},{"key":"10.1016\/j.virs.2022.01.017_bib107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3389\/fcimb.2019.00069","article-title":"Application of CRISPR\/Cas9-Based gene editing in HIV-1\/AIDS therapy","volume":"9","author":"Xiao","year":"2019","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.virs.2022.01.017_bib108","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1817426","article-title":"CRISPR-edited stem cells in a patient with HIV and acute lymphocytic leukemia","volume":"381","author":"Xu","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.virs.2022.01.017_bib109","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-Mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo","volume":"25","author":"Xu","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.01.017_bib110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molcel.2018.02.028","article-title":"Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein","volume":"70","author":"Yan","year":"2018","journal-title":"Mol. Cell."},{"key":"10.1016\/j.virs.2022.01.017_bib111","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1073\/pnas.1407473111","article-title":"Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5\u039432 mutation confers resistance to HIV infection","volume":"111","author":"Ye","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virs.2022.01.017_bib112","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ymthe.2017.03.012","article-title":"In vivo excision of HIV-1 provirus by saCas9 and multiplex single-guide RNAs in animal models","volume":"25","author":"Yin","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virs.2022.01.017_bib113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41421-019-0088-8","article-title":"Optimizing genome editing strategy by primer-extension-mediated sequencing","volume":"5","author":"Yin","year":"2019","journal-title":"Cell Discov."},{"key":"10.1016\/j.virs.2022.01.017_bib114","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.abb7269","article-title":"A\u00a0highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2022.01.017_bib115","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41564-018-0256-x","article-title":"Primate immunodeficiency virus proteins Vpx and Vpr counteract transcriptional repression of proviruses by the HUSH complex","volume":"3","author":"Yurkovetskiy","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virs.2022.01.017_bib116","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib117","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/pbi.13095","article-title":"Establishing CRISPR\/Cas13a immune system conferring RNA virus resistance in both dicot and monocot plants","volume":"17","author":"Zhang","year":"2019","journal-title":"Plant Biotechnol. J"},{"key":"10.1016\/j.virs.2022.01.017_bib118","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/s41587-020-0527-y","article-title":"Dual base editor catalyzes both cytosine and adenine base conversions in human cells","volume":"38","author":"Zhang","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virs.2022.01.017_bib119","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12920-018-0394-2","article-title":"Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling","volume":"11","author":"Zhang","year":"2018","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.virs.2022.01.017_bib120","doi-asserted-by":"crossref","first-page":"16277","DOI":"10.1038\/srep16277","article-title":"CRISPR\/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virs.2022.01.017_bib121","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.imlet.2004.11.026","article-title":"Newly identified host factors modulate HIV replication","volume":"97","author":"Zheng","year":"2005","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.virs.2022.01.017_bib122","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.cell.2020.03.024","article-title":"Glia-to-Neuron conversion by CRISPR-CasRx alleviates symptoms of neurological disease in mice","volume":"181","author":"Zhou","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virs.2022.01.017_bib123","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22000177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X22000177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T19:17:19Z","timestamp":1761851839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X22000177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":123,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1995820X22000177"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2022.01.017","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Updates on CRISPR-based gene editing in HIV-1\/AIDS therapy","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2022.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}